Revenue

With 17 new international pacts, the non-profit now covers over 91% of the global neighboring rights market, simplifying royalty collection for creators.

FibroBiologics' Pete O'Heeron will speak at the H-SPAN summit, highlighting how cell therapy is driving a push for new healthspan legislation.

Energy brand Wip partners with designer Bossi for a shocking leap into luxury fashion, blurring the lines between performance fuel and cultural identity.

A new webinar explores how integrating data into EHRs is overcoming major barriers to improve mental health outcomes. Learn how this tech revolutionizes care.

Kratos will compete in a live fly-off for a massive military contract aimed at fielding 350,000 one-way attack drones, reshaping modern warfare.

With a new CRO from Zoom, LastPass aims to accelerate its B2B strategy, targeting the complex security challenges of the modern SaaS and AI-driven enterprise.

The strategic acquisition of Dignitas Technologies positions By Light to dominate the military simulation market, enhancing DoD readiness for future conflicts.

TruGolf accelerates its stock repurchase program, signaling faith in its future as it unveils new AI-powered tech in a booming indoor golf market.

As Home Depot prepares its year-end report, investors weigh a tough consumer market against the firm's big strategic bets on pro customers and digital tools.

A 79-unit building sale in St. Catharines marks a new investor's arrival, highlighting a trend targeting Southwestern Ontario's rental markets.

ARS Pharma's neffy challenges the EpiPen with new data on efficacy, cost-effectiveness, and patient preference, promising a less intimidating allergy emergency.

Capitol AI appoints Chester Leung as VP of Engineering, signaling a major push to embed security and governance at the core of its enterprise platform.

A new lawsuit claims private equity giant TPG hid implant defects and forced a bankruptcy, leaving thousands of injured patients to pay the price.

As AI projects fail at alarming rates, this startup just raised $2.2M to fix the broken planning process that dooms them from the start.

Celularity Inc. has secured a $12.2M cash injection by selling tax losses, a move set to accelerate its cutting-edge longevity and regenerative medicine pipeline.

A new survey shows most family firms expect a leadership change soon, but few are prepared, creating a high-stakes gap between intent and action.

After a stellar 2025, Corpay is hitting the road for key investor conferences. Can it convince the market its impressive growth is just the beginning?

A new partnership brings powerful sales lift and ROI metrics to Canada's digital out-of-home ad market, transforming it into a performance channel.

Kincell Bio and RegCell partner to bring a groundbreaking, non-gene-edited Treg cell therapy for autoimmune diseases from the lab to clinical trials.

With two high-profile board appointments, Stellaromics signals its ambition to dominate the 3D spatial omics market with its advanced Pyxa™ platform.